AIM: To study the feasibility of panning and screening phage-displaying recombinant single-chain variable fragment (ScFv) of anti-tumor monoclonal antibodies for fixed whole cells as the carriers of mAb-binding antigens. METHODS: The recombinant phage displaying libraries for anti-colorectal tumor mAb MC3Ab, MC5Ab and anti-gastric tumor mAb MGD1 was constructed. Panning and screening were carried out by means of modified fixation of colorectal and gastric tumor cells expressed the mAb-binding antigens. Concordance of binding specificity to tumor cells between phage clones and parent antibodies was analyzed. The phage of positive clones was identified with competitive ELISA, and infected by E.coli HB2151 to express soluble ScFv. RESULTS: The ratio of positive clones to MC3-ScF-MC5-ScFv and MGD1-ScFv were 60 %, 24 % and 30 %. MC3-ScFv had M(r) 32 000 confirmed by Western blot. The specificity to antigen had no difference between 4 positive recombinant phage antibodies and MC3Ab. CONCLUSION: The modified process of fixing whole tumor cells is efficient, convenient and feasible to pan and screen the phage-displaying ScFv of anti-tumor monoclonal antibodies.
AIM: To study the feasibility of panning and screening phage-displaying recombinant single-chain variable fragment (ScFv) of anti-tumor monoclonal antibodies for fixed whole cells as the carriers of mAb-binding antigens. METHODS: The recombinant phage displaying libraries for anti-colorectal tumor mAb MC3Ab, MC5Ab and anti-gastric tumor mAb MGD1 was constructed. Panning and screening were carried out by means of modified fixation of colorectal and gastric tumor cells expressed the mAb-binding antigens. Concordance of binding specificity to tumor cells between phage clones and parent antibodies was analyzed. The phage of positive clones was identified with competitive ELISA, and infected by E.coli HB2151 to express soluble ScFv. RESULTS: The ratio of positive clones to MC3-ScF-MC5-ScFv and MGD1-ScFv were 60 %, 24 % and 30 %. MC3-ScFv had M(r) 32 000 confirmed by Western blot. The specificity to antigen had no difference between 4 positive recombinant phage antibodies and MC3Ab. CONCLUSION: The modified process of fixing whole tumor cells is efficient, convenient and feasible to pan and screen the phage-displaying ScFv of anti-tumor monoclonal antibodies.
Authors: R C Roovers; E van der Linden; A P de Bruïne; J W Arends; H R Hoogenboom Journal: Cancer Immunol Immunother Date: 2001-03 Impact factor: 6.968
Authors: A Goel; S Augustine; J Baranowska-Kortylewicz; D Colcher; B J Booth; G Pavlinkova; M Tempero; S K Batra Journal: Clin Cancer Res Date: 2001-01 Impact factor: 12.531
Authors: A M McCall; L Shahied; A R Amoroso; E M Horak; H H Simmons; U Nielson; G P Adams; R Schier; J D Marks; L M Weiner Journal: J Immunol Date: 2001-05-15 Impact factor: 5.422
Authors: I Ohizumi; S Tsunoda; K Taniguchi; H Saito; K Esaki; K Koizumi; H Makimoto; Y Wakai; J Matsui; Y Tsutsumi; S Nakagawa; N Utoguchi; Y Ohsugi; T Mayumi Journal: Int J Cancer Date: 1998-08-12 Impact factor: 7.396